MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

J&J Vision and Menicon Tackle Myopia with Contact Lens Collaboration

tashatuvango -stock.adobe.com IMG_Apr72021at35825PM.jpg
The collaboration comes on the heels of J&J winning approval from the Japanese Ministry of Health, Labour and Welfare for a contact lens that provides vision correction and an antihistamine drug to help relieve symptoms for people experiencing itchy allergy eyes.

Johnson & Johnson Vision is teaming up with Menicon, a developer of contact lenses to address myopia or near-sightedness in children.

The pact calls for Menicon to develop the contact lenses that would manage the progression of myopia. J&J Vision would focus on expanding the availability of the products across the world.

“For decades, Johnson & Johnson Vision has invested in research collaborations with academic centers, research institutes and leading global health organizations who share our vision of leading with science to reshape the future of myopia and eye health,” said Peter Menziuso, Global President, Johnson & Johnson Vision Care. “Our collaboration with Menicon marks another step forward to bring a portfolio of differentiated products to help manage the progression of myopia in children, as we work towards our vision of helping the world see better, connect better, live better.”

Johnson & Johnson said the collaboration with Menicon is the latest to address the growing myopia epidemic following the development of a myopia management guide with new recommendations for eye care professionals, and the establishment of a novel research partnership with the Singapore National Eye Centre and the Singapore Eye Research Institute. 

The news comes hot on the heels of J&J winning approval from the Japanese Ministry of Health, Labour, and Welfare for a contact lens that provides vision correction and Ketotifen, an antihistamine drug to help relieve symptoms for people experiencing itchy allergy eyes.

The company is calling the approval a “first.”

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish